These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18758188)

  • 21. Primary hyperparathyroidism and nephrolithiasis.
    Vestergaard P
    Ann Endocrinol (Paris); 2015 May; 76(2):116-9. PubMed ID: 25911000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary?
    Cicerello E; Mangano M; Cova GD; Merlo F; Maccatrozzo L
    Arch Ital Urol Androl; 2016 Oct; 88(3):208-211. PubMed ID: 27711095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms.
    Gambaro G; Zaza G; Citterio F; Naticchia A; Ferraro PM
    Urolithiasis; 2019 Feb; 47(1):115-123. PubMed ID: 30470867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Children With Type 1 Spinal Muscular Atrophy Are at Increased Risk for Nephrolithiasis.
    Gök A; Saygılı SK; Kuruğoğlu S; Saltık S; Canpolat N
    Pediatr Neurol; 2024 Jan; 150():32-36. PubMed ID: 37951159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nephrolithiasis related to inborn metabolic diseases.
    Cochat P; Pichault V; Bacchetta J; Dubourg L; Sabot JF; Saban C; Daudon M; Liutkus A
    Pediatr Nephrol; 2010 Mar; 25(3):415-24. PubMed ID: 19156444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges in the diagnostic and therapeutic approach to nephrolithiasis.
    McMahon GM; Seifter JL
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):183-8. PubMed ID: 22257797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics and calcium nephrolithiasis.
    Vezzoli G; Terranegra A; Arcidiacono T; Soldati L
    Kidney Int; 2011 Sep; 80(6):587-93. PubMed ID: 20962745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.
    Halbritter J; Baum M; Hynes AM; Rice SJ; Thwaites DT; Gucev ZS; Fisher B; Spaneas L; Porath JD; Braun DA; Wassner AJ; Nelson CP; Tasic V; Sayer JA; Hildebrandt F
    J Am Soc Nephrol; 2015 Mar; 26(3):543-51. PubMed ID: 25296721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone disease in patients with primary hypercalciuria and calcium nephrolithiasis.
    Tasca A; Dalle Carbonare L; Nigro F; Giannini S
    Urology; 2009 Jul; 74(1):22-7. PubMed ID: 19428073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When to suspect a genetic disorder in a patient with renal stones, and why.
    Ferraro PM; D'Addessi A; Gambaro G
    Nephrol Dial Transplant; 2013 Apr; 28(4):811-20. PubMed ID: 23291371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An unusual patient with hypercalciuria, recurrent nephrolithiasis, hypomagnesemia and G227R mutation of Paracellin-1. An unusual patient with hypercalciuria and hypomagnesemia unresponsive to thiazide diuretics.
    Kutluturk F; Temel B; Uslu B; Aral F; Azezli A; Orhan Y; Konrad M; Ozbey N
    Horm Res; 2006; 66(4):175-81. PubMed ID: 16804318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrolithiasis: treatment, causes, and prevention.
    Hall PM
    Cleve Clin J Med; 2009 Oct; 76(10):583-91. PubMed ID: 19797458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Renal calcium excretion and urolithiasis].
    Aruga S; Honma Y
    Clin Calcium; 2011 Oct; 21(10):1465-72. PubMed ID: 21960231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism.
    Sorensen MD; Duh QY; Grogan RH; Tran TC; Stoller ML
    Surgery; 2012 Mar; 151(3):477-83. PubMed ID: 21893327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms.
    Gambaro G; Vezzoli G; Casari G; Rampoldi L; D'Angelo A; Borghi L
    Am J Kidney Dis; 2004 Dec; 44(6):963-86. PubMed ID: 15558518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium ions promote primary renal epithelial cell differentiation into cells with bone-associated phenotypes via transforming growth factor-β1-induced epithelial-mesenchymal transition in idiopathic hypercalciuria patients.
    He D; Wang S; Jia Z; Cui L; Lu Y; Hu H; Qin B
    Mol Med Rep; 2015 Mar; 11(3):2199-206. PubMed ID: 25394514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the calcium-sensing receptor in reducing the risk for calcium stones.
    Renkema KY; Bindels RJ; Hoenderop JG
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):2076-82. PubMed ID: 21784822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of childhood genetic nephrolithiasis and nephrocalcinosis.
    Gefen AM; Zaritsky JJ
    Front Genet; 2024; 15():1381174. PubMed ID: 38606357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is kidney stone a bone disease?].
    Stoermann Chopard C; Jaeger P
    Rev Med Suisse; 2009 Jun; 5(207):1314-7. PubMed ID: 19626931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on the medical management of stone disease.
    Tracy CR; Pearle MS
    Curr Opin Urol; 2009 Mar; 19(2):200-4. PubMed ID: 19188774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.